ANTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ANTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2025-03-14), AN2 Therapeutics's 6-1 Month Momentum % is 2.88%.
The industry rank for AN2 Therapeutics's 6-1 Month Momentum % or its related term are showing as below:
For the Biotechnology subindustry, AN2 Therapeutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, AN2 Therapeutics's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where AN2 Therapeutics's 6-1 Month Momentum % falls into.
6-1 Month Momentum % is calculated as following:
6-1 Month Momentum % | = | ( Price 1-month ago | / | Price 6-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AN2 Therapeutics (NAS:ANTX) 6-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of AN2 Therapeutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Joshua M Eizen | officer: See Remarks | 3023 MONTBRETIA WAY, SAN RAMON CA 94582 |
Lucy Day | officer: Chief Financial Officer | 2032 MIDDLEFIELD ROAD, PALO ALTO CA 94301 |
Sanjay Chanda | officer: Chief Development Officer | C/O ANACOR PHARMACEUTICALS, INC., 1020 EAST MEADOW CIRCLE, PALO ALTO CA 94303 |
Robin Shane Readnour | director | 3835 CLEGHORN AVENUE, SUITE 300, NASHVILLE TN 37215 |
Joseph S Zakrzewski | director | 509 WATERVIEW PLACE, NEW HOPE PA 18938 |
Eric Easom | director, officer: Chief Executive Officer | 171 FOREST LN., MENLO PARK CA 94025 |
Ra Capital Healthcare Fund Lp | 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Adjuvant Global Health Technology Fund De, L.p. | 10 percent owner | C/O ADJUVANT CAPITAL, L.P., 501 FIFTH AVENUE, SUITE 1404, NEW YORK NY 10017 |
Kabeer Aziz | director | 376 MANHATTAN AVENUE APT. 3, BROOKLYN NY 11211 |
Kevin Michael Krause | officer: Chief Strategy Officer | 369 27TH STREET, SAN FRANCISCO CA 94131 |
Margaret M Fitzpatrick | director | C/O VISTAGEN THERAPEUTICS, INC., 343 ALLERTON AVE., SOUTH SAN FRANCISCO CA 94080 |
Melvin K Spigelman | director | THE MEDICINES COMPANY, 8 CAMPUS DRIVE, PARSIPPANY NJ 07054 |
Ra Capital Nexus Fund Ii, L.p. | 10 percent owner | 200 BERKELEY STREET, 18TH FLOOR, BOSTON MA 02116 |
Adjuvant Global Health Technology Fund, L.p. | 10 percent owner | C/O ADJUVANT CAPITAL, L.P., 501 FIFTH AVENUE, SUITE 1404, NEW YORK NY 10017 |
Michael Adrian Nazak | officer: Chief Accounting Officer | 5941 OPTICAL COURT, SAN JOSE CA 95138 |
From GuruFocus
By Business Wire • 11-09-2023
By Business Wire • 10-18-2023
By Business Wire Business Wire • 02-28-2023
By Business Wire • 02-12-2024
By Business Wire Business Wire • 05-01-2023
By Business Wire • 09-13-2023
By Business Wire Business Wire • 05-25-2023
By Business Wire • 11-14-2024
By GuruFocus Research • 01-12-2024
By Business Wire • 08-16-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.